Market Tracker

08/17 7:18am ET

NxStage Medical Inc (NASDAQ:NXTM)

29.26
Delayed Data
As of Aug 16
 +0.03 / +0.10%
Today’s Change
20.45
Today|||52-Week Range
30.80
+11.64%
Year-to-Date
NxStage Medical Partners Dialyze Direct for On-Site Dialysis
Aug 14 / Zacks.com - Paid Partner Content
Fresenius Medical Inks $2B Deal to Take Over NxStage Medical
Aug 09 / Zacks.com - Paid Partner Content
Foreign Stock Roundup: Novo Nordisk, GOL Linhas Beat on Earnings
Aug 14 / Zacks.com - Paid Partner Content
Company News For August 08, 2017
Aug 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close29.23
Today’s open29.25
Day’s range29.20 - 29.26
Volume1,168,029
Average volume (3 months)1,063,914
Market cap$1.9B
Dividend yield--
Data as of 08/16/2017

Growth & Valuation

Earnings growth (last year)+70.83%
Earnings growth (this year)+51.02%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+9.00%
P/E ratioNM
Price/Sales4.62
Price/Book9.44

Competitors

 Today’s
change
Today’s
% change
INGNInogen Inc+1.49+1.62%
MDXGMiMedx Group Inc+0.19+1.14%
HYHHalyard Health Inc+0.55+1.30%
MMSIMerit Medical System...-0.20-0.49%
Data as of 08/16/2017

Financials

Last reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$366.4M
Annual profit (last year)-$4.8M
Net profit margin-1.30%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Jeffrey H. Burbank
President
Joseph E. Turk
Corporate headquarters
Lawrence, Massachusetts

Forecasts